Repaglinide Teva for Type 2 diabetes mellitus
Quick answer: Repaglinide Teva is used for Type 2 diabetes mellitus as part of a meglitinide (insulin secretagogue) treatment regimen. Stimulates pancreatic beta-cell insulin release by closing ATP-dependent potassium channels The specific dosing for Type 2 diabetes mellitus is determined by your prescriber based on individual factors.
Why is Repaglinide Teva used for Type 2 diabetes mellitus?
Repaglinide Teva belongs to the Meglitinide (insulin secretagogue) class. Stimulates pancreatic beta-cell insulin release by closing ATP-dependent potassium channels This action makes it useful for treating or managing Type 2 diabetes mellitus in patients for whom this approach is clinically appropriate.
It is one of several treatment options. Whether Repaglinide Teva is the right choice for a specific patient depends on the type and severity of Type 2 diabetes mellitus, response to previous treatments, individual risk factors, and clinical guidelines.
Typical dosing for Type 2 diabetes mellitus
Common adult dosing range: 0.5-4 mg before each main meal (max 16 mg/day). The actual dose for Type 2 diabetes mellitus depends on:
- Severity of the condition
- Patient's age, weight, and organ function
- Other medications being taken
- Treatment response and tolerability
For complete dosing details, see the Repaglinide Teva medicine page.
What to expect
Repaglinide Teva treatment for Type 2 diabetes mellitus typically involves:
- Onset of effect: varies by indication and dose — some effects are immediate, others take days to weeks
- Treatment duration: some courses are short-term, others are long-term or lifelong depending on Type 2 diabetes mellitus
- Monitoring: follow-up visits to assess response and adjust dosing
- Side-effect awareness: learning what to expect and what warrants medical attention
Alternatives to consider
If Repaglinide Teva is not appropriate or not tolerated, alternatives within the same class or different therapeutic classes may be considered. See all Meglitinide (insulin secretagogue) for related options.
When to talk to your doctor
Discuss with your prescriber if you experience:
- Inadequate symptom control on Repaglinide Teva
- Side effects affecting daily life
- New medications or supplements that may interact
- Pregnancy planning or pregnancy
- Major changes in health status
Related information
Repaglinide Teva full prescribing information · All Meglitinide (insulin secretagogue) alternatives
Frequently asked questions
How effective is Repaglinide Teva for Type 2 diabetes mellitus?
Effectiveness varies by individual response, dose, and severity. Repaglinide Teva is one of several treatment options for Type 2 diabetes mellitus, supported by clinical evidence within the meglitinide (insulin secretagogue) class. Discuss expected response with your prescriber.
How long do I need to take Repaglinide Teva for Type 2 diabetes mellitus?
Treatment duration depends on the nature of Type 2 diabetes mellitus — some treatments are short-term, others long-term or lifelong. Never stop on your own; discontinuation requires clinical guidance to avoid relapse or rebound effects.
What are the main side effects of Repaglinide Teva when used for Type 2 diabetes mellitus?
Common and serious side effects are class-related and substance-specific. See the full medicine page for the complete profile. Report any unexpected effects to your prescriber.
Are there alternatives to Repaglinide Teva for Type 2 diabetes mellitus?
Yes. Multiple medicines and non-drug options exist for Type 2 diabetes mellitus. Alternatives within the meglitinide (insulin secretagogue) class share mechanisms; other classes may offer different approaches. Discuss with your clinician.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.